Citations

Mayo Clinic

Showing 10 of 108585 citations.

Postoperative opioid-induced respiratory depression or oversedation requiring naloxone treatment in a community hospital: a case series
Newgaard, Olivia , Suginaka, Alex T., Gurrieri, Carmelina , Gurrieri, Carmelina Carmen , Weingarten, Toby N. , Šprung, Juraj

Baylor University Medical Center Proceedings | October 18, 2023 | Volume: 37 | Issue: 1 | Pages: 55-60

10.1080/08998280.2023.2269030 | PMID 38174010 Get It

Relationship Between Lymphovenous Bypass Anastomosis Outcomes and the Number and Types of Anastomosis in the Upper Extremity
Maita, Karla C. , Velasquez, Gioacchino De Sario, Ho, Olivia A. , Torres‐Guzman, Ricardo A. , Ávila, Francisco R. , Garcia, John P. , Borna, Sahar , Forte, Antonio J.

Plastic and Reconstructive Surgery - Global Open | October 18, 2023 | Volume: 11 | Issue: 10S | Pages: 72-73

10.1097/01.gox.0000992252.91816.c7 Get It

Mapping of Neuro-Cardiac Electrophysiology: Interlinking Epilepsy and Arrhythmia
Senapati, Sidhartha Gautam , Bhanushali, Aditi Kishor , Lahori, Simmy , Naagendran, Mridula Sree , Sriram, S Aditya, Ganguly, Arghyadeep , Pusa, Mounika, Damani, Devanshi N. , Kulkarni, Kanchan , Arunachalam, Shivaram P. , Bhanushali, Aditi K, Sriram, Shreya, Arunachalam, S P , Kulkarni, Kanchan

Journal of Cardiovascular Development and Disease | October 18, 2023 | Volume: 10 | Issue: 10 | Pages: 433

10.3390/jcdd10100433 | PMID 37887880 Get It

The interplay between neurology and cardiology has gained significant attention in recent years, particularly regarding the shared pathophysiological mechanisms and clinical comorbidities observed in epilepsy and arrhythmias. Neuro-cardiac electrophysiology mapping involves the comprehensive assessment of both neural and cardiac electrical activity, aiming to unravel the intricate connections and potential cross-talk between the brain and the heart. The emergence of artificial intelligence (AI) has revolutionized the field by enabling the analysis of large-scale data sets, complex signal processing, and predictive modeling. AI algorithms have been applied to neuroimaging, electroencephalography (EEG), electrocardiography (ECG), and other diagnostic modalities to identify subtle patterns, classify disease subtypes, predict outcomes, and guide personalized treatment strategies. In this review, we highlight the potential clinical implications of neuro-cardiac mapping and AI in the management of epilepsy and arrhythmias. We address the challenges and limitations associated with these approaches, including data quality, interpretability, and ethical considerations. Further research and collaboration between neurologists, cardiologists, and AI experts are needed to fully unlock the potential of this interdisciplinary field.
Endoscopic Endonasal Transsphenoidal Resection for MRI-Negative Cushing Disease With 2 Separate Functioning Pituitary Adenomas Neuroendocrine Tumors: 2-Dimensional Operative Video
Shinya, Yuki , Hong, Sukwoo , Gompel, Jamie J. Van , Choby, Garret W, Van Gompel, Jamie J , Shinya, Yuki , Choby, Garret , Bancos, Irina , Giannini, Caterina

Operative Neurosurgery | October 18, 2023 | Volume: 26 | Issue: 2 | Pages: 243-244

10.1227/ons.0000000000000965 | PMID 37850934 Get It

Commentary: Transcavernous Surgical Approach for the Treatment of Carotid-Cavernous Fistula: 2-Dimensional Operative Video
Bathini, Abhijith , Qazi, Zeeshan, Bathini, Abhijith R , Zeeshan, Qazi , Bendok, Bernard R.

Operative Neurosurgery | October 18, 2023 | Volume: 26 | Issue: 1 | Pages: 119-120

10.1227/ons.0000000000000954 | PMID 37850914 Get It

Optimal Embryo Selection: The Irreplaceable Role of the Embryologist in an Age of Advancing Technology
Rauchfuss, Lauren Kendall , Zhao, Yulian , Galantis, Terri, Fredrickson, J.R., Barud, K.M., Fredrickson, Jolene, Barud, Kathrynne, Shenoy, Chandra, Walker, David , Shenoy, Chandra C.

Journal of Human Reproductive Sciences | October 18, 2023 | Volume: 16 | Issue: 3 | Pages: 227-232

10.4103/jhrs.jhrs_98_23 | PMID 38045503 Get It

Background: Time-lapse incubators allow for ongoing evaluation of embryos without culture condition disruption. The use of time-lapse incubation has been shown to improve outcomes either by improving overall conditions or providing additional information to aid in embryo selection for transfer. Time-lapse incubators can also utilise morphokinetic models to rank embryos based on morphokinetic parameters. We sought to compare a morphokinetic model for embryo comparison to traditional morphologic evaluation. Aims: The aim of the study is to compare a morphokinetic model for embryo comparison to traditional morphologic evaluation. Settings and Design: This is a retrospective cohort design. Materials and Methods: Embryos cultured in a time-lapse culture system that had traditional morphologic evaluation, morphokinetic modelling and known live birth outcomes were included in this study. Embryos with unknown competence were excluded, including when two embryos were transferred with a single live birth resulted. Statistical Analysis Used: Receiver operating characteristic (ROC) curves were determined for both the morphologic analysis and the morphokinetic model on culture day 3 and day 5. Using the ROC-determined cutoff that optimised both sensitivity and specificity, a binary outcome for each test was analysed using agreement statistics to determine if one method of embryo evaluation was superior to the other. Results: Morphological and morphokinetic grading were both predictive of embryo competence on days 3 and 5. However, on day 3, morphologic grading was superior to morphokinetic grading with area under the curve (AUC) of 0.66 ( P < 0.001) and 0.58 ( P = 0.009), respectively. Contrarily, on day 5, the morphokinetic model had a higher AUC of 0.65 ( P = 0.03) compared to the morphologic grading, AUC 0.56 ( P = 0.02). Conclusion: Traditional morphology was noted to be a better diagnostic tool (higher AUC) on culture day 3 while a morphokinetic model was superior on day 5.
The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort
Touroutoglou, Alexandra , Katsumi, Yuta , Brickhouse, Michael , Zaitsev, Alexander, Eckbo, Ryan, Aisen, Paul, Dage, Jeffrey L. , Eloyan, Ani , Ghetti, Bernardino , Griffin, Percy , Hammers, Dustin B. , Jack, Clifford R. , Kramer, Joel H. , Joie, Renaud La , Mundada, Nidhi S. , Kukull, Walter A. , Polsinelli, Angelina J. , Rumbaugh, Malia, Soleimani‐Meigooni, David N. , Toga, Arthur W. , Vemuri, Prashanthi , Day, Gregory S. , Duara, Ranjan , Graff‐Radford, Neill R. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan , Rogalskı, Emily , Salloway, Stephen , Sha, Sharon, Turner, Raymond Scott , Wingo, Thomas S. , Carrillo, María C. , Rabinovici, Gil D. , Apostolova, Liana G. , Jack, Clifford R , Vemuri, Prashanthi , Day, Gregory S , La Joie, Renaud , Rabinovici, Gil D , Ghetti, Bernardino F , Wingo, Thomas S , Dage, Jeffrey L , Beckett, Laurel , Foroud, Tatiana , Hammers, Dustin B , Iaccarino, Leonardo , Koeppe, Robert A. , Murray, Melissa E. , Nudelman, Kelly , Atri, Alireza , Duara, Ranjan , Honig, Lawrence S. , Jones, David T. , Masdeu, Joseph C , Musiek, Erik , Sha, Sharon J. , Wolk, David A. , Womack, Kyle , Dickerson, Bradford Clark

Alzheimer's & Dementia | October 18, 2023 | Volume: 19 | Issue: S9 | Pages: No page available

10.1002/alz.13466 | PMID 37850549 Get It

Abstract INTRODUCTION Magnetic resonance imaging (MRI) research has advanced our understanding of neurodegeneration in sporadic early‐onset Alzheimer's disease (EOAD) but studies include small samples, mostly amnestic EOAD, and have not focused on developing an MRI biomarker. METHODS We analyzed MRI scans to define the sporadic EOAD‐signature atrophy in a small sample (n = 25) of Massachusetts General Hospital (MGH) EOAD patients, investigated its reproducibility in the large longitudinal early‐onset Alzheimer's disease study (LEADS) sample (n = 211), and investigated the relationship of the magnitude of atrophy with cognitive impairment. RESULTS The EOAD‐signature atrophy was replicated across the two cohorts, with prominent atrophy in the caudal lateral temporal cortex, inferior parietal lobule, and posterior cingulate and precuneus cortices, and with relative sparing of the medial temporal lobe. The magnitude of EOAD‐signature atrophy was associated with the severity of cognitive impairment. DISCUSSION The EOAD‐signature atrophy is a reliable and clinically valid biomarker of AD‐related neurodegeneration that could be used in clinical trials for EOAD. Highlights We developed an early‐onset Alzheimer's disease (EOAD)–signature of atrophy based on magnetic resonance imaging (MRI) scans. EOAD signature was robustly reproducible across two independent patient cohorts. EOAD signature included prominent atrophy in parietal and posterior temporal cortex. The EOAD‐signature atrophy was associated with the severity of cognitive impairment. EOAD signature is a reliable and clinically valid biomarker of neurodegeneration.
The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?
Gunasekera, Charlene L., Sirven, Joseph I , Feyissa, Anteneh M. , Feyissa, A M

Journal of Central Nervous System Disease | October 18, 2023 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/11795735231209209 | PMID 37868934 Get It

Antiseizure medications (ASMs) are the mainstay of symptomatic epilepsy treatment. The primary goal of pharmacotherapy with ASMs in epilepsy is to achieve complete seizure remission while minimizing therapy-related adverse events. Over the years, more ASMs have been introduced, with approximately 30 now in everyday use. With such a wide variety, much guidance is needed in choosing ASMs for initial therapy, subsequent replacement monotherapy, or adjunctive therapy. The specific ASMs are typically tailored by the patient’s related factors, including epilepsy syndrome, age, sex, comorbidities, and ASM characteristics, including the spectrum of efficacy, pharmacokinetic properties, safety, and tolerability. Weighing these key clinical variables requires experience and expertise that may be limited. Furthermore, with this approach, patients may endure multiple trials of ineffective treatments before the most appropriate ASM is found. A more reliable way to predict response to different ASMs is needed so that the most effective and tolerated ASM can be selected. Soon, alternative approaches, such as deep machine learning (ML), could aid the individualized selection of the first and subsequent ASMs. The recognition of epilepsy as a network disorder and the integration of personalized epilepsy networks in future ML platforms can also facilitate the prediction of ASM response. Augmenting the conventional approach with artificial intelligence (AI) opens the door to personalized pharmacotherapy in epilepsy. However, more work is needed before these models are ready for primetime clinical practice.
Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measure
Gebre, Robel K , Raghavan, Sheela Kumari, Wiste, Heather J. , Sparrman, Kohl L. Johnson, Costoya‐Sánchez, Alejandro , Schwarz, Christopher G. , Spychalla, Anthony J., Lowe, Val J. , Graff‐Radford, Jonathan , Petersen, Ronald C. , Schöll, Michael , Vemuri, Prashanthi , Rial, Alexis Moscoso , Johnson Sparrman, Kohl L, Schwarz, Christopher G , Knopman, David S. , Petersen, Ronald C , Schöll, Michael , Jack, Clifford R , Vemuri, Prashanthi , Heeman, Fiona , Knopman, David S. , Jack, Clifford R.

No container title available | October 18, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3290598/v1 | PMID 37886506 Get It

Abstract Alzheimer's disease (AD) exhibits spatially heterogeneous 3R/4R tau pathology distributions across participants, making it a challenge to quantify extent of tau deposition. Utilizing Tau-PET from three independent cohorts, we trained and validated a machine learning model to identify visually positive Tau-PET scans from regional SUVR values and developed a novel summary measure, THETA, that accounts for heterogeneity in tau deposition. The model for identification of tau positivity achieved a balanced test accuracy of 95% and accuracy of ≥87% on the validation datasets. THETA captured heterogeneity of tau deposition, had better association with clinical measures, and corresponded better with visual assessments in comparison with the temporal meta-region-of-interest Tau-PET quantification methods. Our novel approach aids in identification of positive Tau-PET scans and provides a quantitative summary measure, THETA, that effectively captures the heterogeneous tau deposition seen in AD. The application of THETA for quantifying Tau-PET in AD exhibits great potential.
Access to Cancer Care in LMIC - Navigating Current Challenges
Sridhar, Arthi , Buswell, Lori , Drapek, Lorraine C. , Garcia, Erica Ruiz, Habimana, Olivier , Loon, Katherine Van , Garcia, Erica Ruiz, Parikh, Aparna R.

International Journal of Cancer Care and Delivery | October 18, 2023 | Volume: 3 | Issue: 2 | Pages: No page available

10.53876/001c.88502 Get It

At the Summit on Cancer Health Disparities held in 2023, the session on Access to Cancer Care in Low- and middle- income countries (LMIC) highlighted several efforts globally. The collaborative efforts of Dana Farber Cancer Institute and the Ministry of Health in spearheading the Butaro Cancer Center of Excellence (BCCOE) in Rwanda was one such initiative. They were able to set up the BCCOE to address the unmet need of cancer care in this area and have trained nurses in East Africa to help establish other similar centers. They also serve as the single radiotherapy center for the entire of the country. Another such collaborative effort between Massachusetts General Hospital and the cancer center in Botswana in setting up sexual health education initiatives for women undergoing pelvic radiation was highlighted. They started with a quality improvement project to demonstrate the benefit of sexual health education and proper vaginal dilator use amongst women in this demographic. They were able to demonstrate that 90% of patients were able to complete an in-person 6-week workshop with clear benefits noted on a long-term basis. To highlight examples of best practice examples of equitable partnerships, examples of partnerships between Instituto Nacional de Cancerologia in Mexico City and UCSF was described. It was emphasized that for successful collaborations, equitable bidirectional partnerships are key. The thought leaders in this field also highlighted challenges associated with global oncology and the need for inclusion of minorities in clinical trials to improve cancer care for all globally.